Finance

Beta
Lists
RVPH:OTCMKTS
Reviva Pharmaceuticals Holdings Inc
$0.72
+16.79%
(+0.10) 1D
Jun 5, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for RVPH...
Open
$0.58
High
$0.72
Low
$0.58
Mkt. cap
9.41M
Avg. vol.
730.70K
Volume
162.77K
52-wk high
$17.98
52-wk low
$0.26
EPS
-$4.55
Beta
0.56
Shares outstanding
13.11M
No. of employees
14
Open
$0.58
High
$0.72
Low
$0.58
Mkt. cap
9.41M
Avg. vol.
730.70K
Volume
162.77K
52-wk high
$17.98
52-wk low
$0.26
EPS
-$4.55
Beta
0.56
Shares outstanding
13.11M
No. of employees
14
Analyst outlook
Analyst Ratings
Based on 3 analysts giving stock ratings to RVPH in the past 3 months
Buy
Buy
2
Hold
1
Sell
0
12 month forecast
Based on 3 Wall Street analysts offering 12 month price targets for RVPH in the last 3 months.
Highest
Current $0.72
$30.00 (+4,095.80%)
Average
$15.50 (+2,067.83%)
Lowest
$1.00 (+39.86%)
News stories
From sources across the web
About Reviva Pharmaceuticals Holdings Inc
CEO-
Employees14
Founded2018
HeadquartersCupertino, California, United States
SectorPharmaceutical industry
Websiterevivapharma.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
3.72M
2.13M
1.74M
1.44M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.35M
1.90M
1.82M
1.84M
Operating expense
6.07M
4.03M
3.56M
3.27M
Total operating expenses
6.07M
4.03M
3.56M
3.27M
Operating income
-6.07M
-4.03M
-3.56M
-3.27M
Other non operating income
9.28K
-34.59K
45.32K
-3.39K
EBT including unusual items
-6.05M
-4.01M
-3.36M
-3.19M
EBT excluding unusual items
-6.05M
-4.01M
-3.36M
-3.19M
Income tax expense
7.95K
2.84K
2.88K
3.35K
Effective tax rate
-0.13%
-0.07%
-0.09%
-0.10%
Other operating expenses
-
-
-
-
Net income
-6.05M
-4.01M
-3.37M
-3.20M
Net profit margin
-
-
-
-
Earnings per share
-2.40
-1.20
-5.19
-0.46
Interest and investment income
22.85K
59.10K
148.93K
89.35K
Interest expense
-4.80K
-2.60K
-
-6.65K
Net interest expenses
18.05K
56.50K
148.93K
82.70K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer